Fabrication of chitosan/TPP nanoparticles as a carrier towards the treatment of cancer

International Journal of Drug Delivery

Volumn 5, Issue 1, 2013, Pages 35-42

  Saravanabhavan, Shanmuga Sundar ^a   Bose, Rekha ^a   Skylab, Sridhar ^a   Dharmalingam, Sangeetha ^a  

^a ANNA UNIVERSITY   (India)

Author keywords

5 FU; Cancer; Chitosan; MTT

Indexed keywords

CHITOSAN NANOPARTICLE; FLUOROURACIL; NANOPARTICLE; TRIPOLYPHOSPHATE NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CANCER THERAPY; CELL METABOLISM; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIFFUSION; DRUG CYTOTOXICITY; DRUG DEGRADATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG UPTAKE; GELATION; IN VITRO STUDY; IONIC GELATION; MTT ASSAY; NANOFABRICATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE; SYNTHESIS; ZETA POTENTIAL;

EID: 84886047713     PISSN: None     EISSN: 09750215     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Nanotechnology-based approaches in anticancer research. International Journal of Nanomedicine. 2012; 7: 4391.
2. Talekar M, Kendall J, Denny W, Garg S. Targeting of nanoparticles in cancer: drug delivery and diagnostics. Anti¬Cancer Drugs. 2011; 22(10): 949.
3. Cho K, Wang X, Nie S, Shin DM. Therapeutic Nanoparticles for Drug Delivery in Cancer. Clinical Cancer Research. 2008; 14(5): 1310-1316.
4. Aravind A, Yoshida Y, Maekawa T, Kumar DS. Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy. Drug Delivery and Translational Research. 2012; 2: 1-19.
5. Morgillo F, Lee HY. Resistance to epidermal growth factor receptor-targeted therapy. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. 2005; 8(5): 298.
6. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug development and industrial pharmacy. 1998; 24(12): 1113-1128.
7. Morrow KJ, Bawa R, Wei C. Recent Advances in Basic and Clinical Nanomedicine. Med Clin N Am. 2007; 91: 805-843.
8. Singh A, Dilnawaz F, Mewar S, Sharma U, Jagannathan NR, Sahoo SK. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl Mater Interfaces. 2011; 3(3): 842-856.
9. Aydin RST, Pulat M. 5-Fluorouracil Encapsulated Chitosan Nanoparticles for pH-Stimulated Drug Delivery: Evaluation of Controlled Release Kinetics. Journal of Nanomaterials. 2012; Article ID 313961: 10 pages.
10. Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Review of Medical Devices. 2004; 1(1): 115-125.
11. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Advanced Drug Delivery Reviews. 2004; 56(11): 1649-1659.
12. Bhatia A, Shard P, Chopra D, Mishra T. Chitosan nanoparticles as Carrier of Immunorestoratory plant extract: synthesis, characterization and Immunorestoratory eficacy. International Journal of Drug Delivery. 2011; 3(2): 381-385.
13. Chaudhury A, Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS Pharm Sci Tech. 2011; 12(1): 10-20.
14. Bowman, K.; Leong K. W. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine. 2006; 1(2): 117-28.
15. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release. 2004; 100(1): 5-28.
16. Shanmuga Sundar S, Sangeetha D. Fabrication and evaluation of electrospun collagen/poly(N-isopropyl acrylamide)/chitosan mat as blood-contacting biomaterials for drug delivery. J Mater Sci: Mater Med, 2012, 23:1421-1430. DOI 10.1007/s10856-012-4610-x.
17. Yue ZG, Wei W, Lv PP, Yue H, Wang LY, Su ZG, Ma GH. Surface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based Nanoparticles. Biomacromolecules. 2011; 12(7): 2440-2446.
18. Rajendran L, Kn Lker HJ, Simons K. Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discovery. 2010; 9: 29-42.
19. Hou Y, Hu J, Park H, Lee M. Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications. Journal of Biomedical Materials Research Part A. 2012; 100A (4): 939-947.
20. Ritger PL, Peppas NA. A Simple Equation for Description of Solute Release. I. Fickian and non-Fickian Release from Non-Swellable Devices in the Form of Slabs, Spheres, Cylinders or Discs. J Control Rel. 1987; 5: 23-36.
21. Ritger PL, Peppas NA. A Simple Equation for Description of Solute Release. II. Fickian and Anomalous Release from Swellable Devices. J Control Rel. 1987; 5: 37-42.
22. Shanmuga Sundar S, Sangeetha D. Investigation on sulphonated PEEK beads for drug delivery, bioactivity and tissue engineering applications. J Mater Sci. 2012; 47(6): 2736-2742. DOI 10.1007/s10853-011-6100-9
23. Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011; 63(3): 136-151.
24. Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Drug Deliv Rev. 2011; 63(3): 131-135.
25. Gindy ME, Prud'homme RK. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv. 2009; 6(8): 865-878
26. Gorgieva S, Kokol V. Preparation, characterization, and in vitroenzymatic degradation of chitosan-gelatine hydrogel scaffolds as potential biomaterials. Journal of Biomedical Materials Research Part A. 2012; DOI: 10.1002/jbm.a.34106.
27. Lim SM, Song DK, Oh SH, Lee-Yoon DS, Bae EH, Lee JH. In vitro and in vivodegradation behavior of acetylated chitosan porous beads. J Biomater Sci Polym E. 2008; 19: 453-466.
28. Tomihata K, Ikada Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials. 1997; 16: 567-575.
29. Freier T, Koh HS, Kazazian K, Shoichet MS. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials. 2005; 26(29): 5872-5878.
30. Yassin AEB, Anwer MK, Mowafy HA, El-Bagory IM, Bayomi MA, Alsarra IA. Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. International journal of medical sciences. 2010; 7(6): 398.
31. Zhang J, Du J, Yan M, Dhaliwal A, Wen J, Liu F, Segura T, Lu Y. Synthesis of protein nano¬conjugates for cancer therapy. Nano Research. 2011; 4(5): 425-433.